when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Approval · news · pharmadog

← back to Approval

News · Approval

650 stories

Jul 16, 26STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvalsstat

Jul 16, 26Updated: Merck beats AstraZeneca to approval for first PCSK9 pillendpoints

Jul 16, 26STAT+: Amylyx nears pivotal endocrine drug study readoutstat

Jul 16, 26Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 updatefiercebiotech

Jul 16, 26Racing Takeda, InnoCare reports TYK2 inhibitor win in phase 2 vitiligo trialfiercebiotech

Jul 16, 26Recon: Lilly to buy psychedelic developer AtaiBeckley for up to $3.8B; FDA approves Merck’s novel cholesterol drugraps

Jul 15, 26Celcuity gains FDA approval for closely watched breast cancer drugbiopharma dive

Jul 15, 26Merck ADC, in China study, shows potential to replace chemo in lung cancerbiopharma dive

Jul 15, 26Radiopharma maker AdvanCell hauls in $315M for Pluvicto challengerendpoints

Jul 15, 26Kelun’s Merck-partnered ADC notches late-stage NSCLC win alongside Keytrudabiospace

Jul 15, 26Braveheart files for IPO to fund Phase 3 of Hengrui's Cytokinetics rivalendpoints

Jul 15, 26Why Axiom hopes it’s ‘solved 2 major potholes’ that have hurt other stem cell biotechsfiercebiotech

Jul 14, 26Celcuity wins approval for breast cancer drug Revtorpykendpoints

Jul 14, 26The risk of refusing a newborn’s vitamin K shotstat

Jul 14, 26STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and morestat

Jul 14, 26STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study showsstat

Jul 14, 26Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugsbiopharma dive

Jul 14, 26FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientiststat

Jul 13, 26STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patentsstat

Jul 13, 26FDA finalizes guidance on psychedelics, plans broader hearingendpoints

Jul 13, 26Freenome colorectal cancer test data improve on earlier resultsbiopharma dive

Jul 13, 26Agenus surges on study pivot; Apnimed lines up an IPObiopharma dive

Jul 13, 26Tris Pharma's CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trialendpoints

Jul 13, 26STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and morestat

Jul 13, 26STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to comestat

Jul 12, 26STAT+: Tau in the spotlight at Alzheimer’s conferencestat

Jul 10, 26Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injectorendpoints

Jul 10, 26STAT+: Roche ends Huntington’s gene-silencing programsstat

Jul 10, 26STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and morestat

Jul 9, 26Roche scraps two Ionis-partnered Huntington’s drugsbiopharma dive

← prevpage 12 of 22next →